​

Merck (MRK) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChartTranscripts

Merck Revenue Highlights

Latest Revenue (Y)

$60.12B

Latest Revenue (Q)

$16.66B

Main Segment (Y)

Pharmaceutical segment

Main Geography (Y)

UNITED STATES

Merck Revenue by Period

Merck Revenue by Year

DateRevenueChange
2023-12-31$60.12B1.40%
2022-12-31$59.28B21.72%
2021-12-31$48.70B1.48%
2020-12-31$47.99B2.46%
2019-12-31$46.84B10.75%
2018-12-31$42.29B5.41%
2017-12-31$40.12B0.79%
2016-12-31$39.81B0.78%
2015-12-31$39.50B-6.48%
2014-12-31$42.24B-4.08%
2013-12-31$44.03B-6.84%
2012-12-31$47.27B-1.62%
2011-12-31$48.05B4.48%
2010-12-31$45.99B67.66%
2009-12-31$27.43B15.00%
2008-12-31$23.85B-1.44%
2007-12-31$24.20B6.90%
2006-12-31$22.64B2.84%
2005-12-31$22.01B-4.04%
2004-12-31$22.94B2.01%
2003-12-31$22.49B-56.58%
2002-12-31$51.79B8.54%
2001-12-31$47.72B18.22%
2000-12-31$40.36B23.38%
1999-12-31$32.71B21.62%
1998-12-31$26.90B13.80%
1997-12-31$23.64B19.21%
1996-12-31$19.83B18.87%
1995-12-31$16.68B11.43%
1994-12-31$14.97B42.59%
1993-12-31$10.50B-

Merck generated $60.12B in revenue during NA 2023, up 1.40% compared to the previous quarter, and up 142.14% compared to the same period a year ago.

Merck Revenue by Quarter

DateRevenueChange
2024-09-30$16.66B3.10%
2024-06-30$16.16B2.42%
2024-03-31$15.78B7.83%
2023-12-31$14.63B-8.34%
2023-09-30$15.96B6.17%
2023-06-30$15.04B3.78%
2023-03-31$14.49B4.75%
2022-12-31$13.83B-7.55%
2022-09-30$14.96B2.51%
2022-06-30$14.59B-8.23%
2022-03-31$15.90B17.60%
2021-12-31$13.52B2.79%
2021-09-30$13.15B15.37%
2021-06-30$11.40B7.29%
2021-03-31$10.63B-15.09%
2020-12-31$12.52B14.51%
2020-09-30$10.93B16.85%
2020-06-30$9.35B-22.43%
2020-03-31$12.06B1.59%
2019-12-31$11.87B-4.27%
2019-09-30$12.40B5.42%
2019-06-30$11.76B8.73%
2019-03-31$10.82B-1.65%
2018-12-31$11.00B1.89%
2018-09-30$10.79B3.14%
2018-06-30$10.46B4.26%
2018-03-31$10.04B-3.80%
2017-12-31$10.43B1.05%
2017-09-30$10.32B3.98%
2017-06-30$9.93B5.26%
2017-03-31$9.43B-6.73%
2016-12-31$10.12B-4.00%
2016-09-30$10.54B7.03%
2016-06-30$9.84B5.71%
2016-03-31$9.31B-8.84%
2015-12-31$10.21B1.41%
2015-09-30$10.07B2.94%
2015-06-30$9.79B3.82%
2015-03-31$9.43B-10.08%
2014-12-31$10.48B-0.71%
2014-09-30$10.56B-3.45%
2014-06-30$10.93B6.53%
2014-03-31$10.26B-9.33%
2013-12-31$11.32B2.61%
2013-09-30$11.03B0.20%
2013-06-30$11.01B3.18%
2013-03-31$10.67B-9.08%
2012-12-31$11.74B2.17%
2012-09-30$11.49B-6.69%
2012-06-30$12.31B4.94%
2012-03-31$11.73B-4.58%
2011-12-31$12.29B2.26%
2011-09-30$12.02B-1.06%
2011-06-30$12.15B4.93%
2011-03-31$11.58B-4.25%
2010-12-31$12.09B8.71%
2010-09-30$11.13B-1.95%
2010-06-30$11.35B-0.66%
2010-03-31$11.42B13.16%
2009-12-31$10.09B66.84%
2009-09-30$6.05B2.54%
2009-06-30$5.90B9.56%
2009-03-31$5.39B-10.73%
2008-12-31$6.03B1.49%
2008-09-30$5.94B-1.78%
2008-06-30$6.05B3.95%
2008-03-31$5.82B-6.74%
2007-12-31$6.24B-

Merck generated $16.66B in revenue during Q3 2024, up 3.10% compared to the previous quarter, and up 110.79% compared to the same period a year ago.

Merck Revenue Breakdown

Merck Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 22Dec 21Dec 20Dec 19Dec 18
Pharmaceutical segment$52.01B$42.75B$43.02B$41.75B$37.69B
Other Segments--$23.00M$175.00M$250.00M
Animal Health segment$5.55B$5.57B$4.70B$4.39B$4.21B

Merck's latest annual revenue breakdown by segment (product or service), as of Dec 22: Pharmaceutical segment (90.36%), and Animal Health segment (9.64%).

Quarterly Revenue by Product

Product/ServiceSep 24Jun 24Mar 24Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19
Pharmaceutical segment$14.94B$14.41B$14.01B$14.26B$13.46B$12.72B$12.18B$12.96B$12.76B$14.11B$12.04B$11.50B$9.98B$10.68B$11.37B$11.32B$9.68B$10.65B$10.53B$11.10B
Animal Health segment$1.49B$1.48B$1.51B$1.40B$1.46B$1.49B$1.23B$1.37B$1.47B$1.48B$1.26B$1.42B$1.47B$1.42B$1.17B$1.22B$1.10B$1.21B$1.12B$1.12B
Other Segments----------------$23.00M$42.00M$46.00M-

Merck's latest quarterly revenue breakdown by segment (product or service), as of Sep 24: Pharmaceutical segment (90.95%), and Animal Health segment (9.05%).

Merck Revenue Breakdown by Country

Annual Revenue by Country

CountryDec 22Dec 21Dec 20Dec 19Dec 18
UNITED STATES$27.21B$22.43B$21.03B$20.32B$18.21B
Latin America$2.58B$2.21B$2.27B$2.47B$2.42B
JAPAN$3.63B$2.73B$3.38B$3.58B$3.21B
EMEA$14.49B$13.34B$13.60B$12.71B$12.21B
CHINA$5.19B$4.38B$3.62B$3.21B$2.18B
Other Countries$2.57B$1.22B$1.23B$1.61B$1.15B
Asia Pacific$12.43B$2.41B$2.86B$2.94B$2.91B

Merck's latest annual revenue breakdown by geography, as of Dec 22: UNITED STATES (39.95%), EMEA (21.28%), Asia Pacific (18.26%), CHINA (7.62%), JAPAN (5.33%), Latin America (3.79%), and Other Countries (3.77%).

Quarterly Revenue by Country

CountrySep 24Jun 24Mar 24Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19
EMEA$3.58B$3.52B$3.56B$3.33B$3.35B$3.30B$3.27B$3.29B$3.58B$4.36B$3.43B$3.34B$3.33B$3.73B$3.54B$3.45B$3.07B$3.53B$3.25B$3.19B
UNITED STATES$8.74B$7.88B$7.48B$7.71B$7.02B$6.66B$6.28B$7.32B$6.24B$7.34B$6.26B$6.28B$5.10B$5.14B$5.63B$5.63B$4.63B$5.14B$5.14B$5.53B
Asia Pacific$2.78B$3.25B$3.32B$781.00M$848.00M$846.00M$822.00M$854.00M$1.01B$930.00M$625.00M$613.00M$594.00M$751.00M$735.00M$735.00M$666.00M$728.00M$726.00M$756.00M
Latin America$936.00M$858.00M$796.00M$895.00M$742.00M$661.00M$649.00M$684.00M$642.00M$607.00M$575.00M$599.00M$532.00M$569.00M$604.00M$604.00M$510.00M$556.00M$580.00M$671.00M
CHINA--$1.77B$1.69B$1.91B$1.72B$1.23B$1.44B$1.37B$1.14B$1.37B$1.31B$975.00M$927.00M$909.00M$1.02B$834.00M$864.00M$784.00M$914.00M
Other Countries--$621.00M$469.00M$491.00M$545.00M$728.00M$698.00M$637.00M$534.00M$462.00M$379.00M$207.00M$238.00M$225.00M$289.00M$290.00M$427.00M$437.00M$423.00M
JAPAN--$821.00M$1.08B$675.00M$758.00M$853.00M$673.00M$1.11B$989.00M$797.00M$638.00M$661.00M$730.00M$870.00M$828.00M$867.00M$811.00M$944.00M$919.00M

Merck's latest quarterly revenue breakdown by geography, as of Sep 24: UNITED STATES (54.49%), EMEA (22.35%), Asia Pacific (17.33%), and Latin America (5.84%).

Merck Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
JNJJohnson & Johnson$85.15B$22.47B
MRKMerck$60.12B$16.66B
PFEPfizer$58.50B$17.70B
ABBVAbbVie$54.32B$14.46B
BMYBristol-Myers Squibb Company$45.01B$11.89B
LLYEli Lilly and Company$34.12B$11.44B
AMGNAmgen$28.19B$8.50B
GILDGilead Sciences$27.12B$7.55B

MRK Revenue FAQ

What is Merck’s yearly revenue?

Merck's yearly revenue for 2023 was $60.12B, representing an increase of 1.40% compared to 2022. The company's yearly revenue for 2022 was $59.28B, representing an increase of 21.72% compared to 2021. MRK's yearly revenue for 2021 was $48.7B, representing an increase of 1.48% compared to 2020.

What is Merck’s quarterly revenue?

Merck's quarterly revenue for Q3 2024 was $16.66B, a 3.10% increase from the previous quarter (Q2 2024), and a 4.35% increase year-over-year (Q3 2023). The company's quarterly revenue for Q2 2024 was $16.16B, a 2.42% increase from the previous quarter (Q1 2024), and a 7.46% increase year-over-year (Q2 2023). MRK's quarterly revenue for Q1 2024 was $15.78B, a 7.83% increase from the previous quarter (Q4 2023), and a 8.89% increase year-over-year (Q1 2023).

What is Merck’s revenue growth rate?

Merck's revenue growth rate for the last 3 years (2021-2023) was 23.43%, and for the last 5 years (2019-2023) was 28.34%.

What are Merck’s revenue streams?

Merck's revenue streams in c 22 are Pharmaceutical segment, and Animal Health segment. Pharmaceutical segment generated $52B in revenue, accounting 90.36% of the company's total revenue, up 21.64% year-over-year. Animal Health segment generated $5.55B in revenue, accounting 9.64% of the company's total revenue, down -0.32% year-over-year.

What is Merck’s main source of revenue?

For the fiscal year ending Dec 22, the largest source of revenue of Merck was Pharmaceutical segment. This segment made a revenue of $52B, representing 90.36% of the company's total revenue.